Original Literature | Model OverView |
---|---|
Publication
Title
CD14 and other recognition molecules for lipopolysaccharide: a review.
Affiliation
Department of Anatomy and Physiology, College of Veterinary Medicine, KansasState University, Manhattan 66506, USA.
Abstract
Lipopolysaccharide (LPS) or endotoxin elicits a broad, non-specific cascade ofevents in vivo, resulting in secretion of a variety of potent mediators andcytokines produced primarily by activated macrophages and monocytes. Theoverproduction of these effector molecules, such as interleukin-1 and tumornecrosis factor-alpha, contributes to the pathophysiology of endotoxic shock.Cellular recognition of LPS involves several different molecules, includingcluster of differentiation antigen CD14. A thorough understanding of theinteraction of LPS with cells of the immune system is necessary before effectivepreventative or therapeutic measures can be designed to limit the host responseto endotoxin. This review discusses the role of CD14 and other LPS-recognitionmolecules in LPS-mediated macrophage activation.
PMID
7542643
|
Entity
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
LPS:LBP
--
e11
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m11
0
infinite
0
--
CD14
--
e12
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m12
0
infinite
0
--
IL-1beta
--
e13
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m13
0
infinite
0
--
csml-variable:Double
m14
0
infinite
0
--
TNF-alpha
--
e15
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m15
0
infinite
0
--
CD14 mAb
--
e16
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m16
0
infinite
0
--
csml-variable:Double
m17
0
infinite
0
--
IL-1
--
e18
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m18
0
infinite
0
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
IL-6
--
e20
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m20
0
infinite
0
--
csml-variable:Double
m21
0
infinite
0
--
IL-8
--
e22
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m22
0
infinite
0
--
TNF-alpha
--
e23
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m23
0
infinite
0
--
TNFR
--
e24
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m24
0
infinite
0
--
TNF-alpha:TNFR
--
e25
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m25
0
infinite
0
--
csml-variable:Double
m26
0
infinite
0
--
GM-CSF
--
e27
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m27
0
infinite
0
--
GM-CSFR
--
e28
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m28
0
infinite
0
--
GM-CSF:GMCSFR
--
e29
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
G-CSF
--
e30
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m30
0
infinite
0
--
GCSFR
--
e31
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m31
0
infinite
0
--
G-CSF:G-CSFR
--
e32
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m32
0
infinite
0
--
formyl peptide
--
e33
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m33
0
infinite
0
--
sCD14
--
e34
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m34
0
infinite
0
--
LPS:sCD14
--
e35
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m35
0
infinite
0
--
csml-variable:Double
m36
0
infinite
0
--
LPS:CD14
--
e38
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m38
0
infinite
0
--
IL-1beta
--
e39
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
CD11a:CD18
--
e40
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m40
0
infinite
0
--
LPS:CD11a:CD18
--
e41
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m41
0
infinite
0
--
Cd11b:CD18
--
e42
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m42
0
infinite
0
--
LPS:CD11b:CD18
--
e43
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m43
0
infinite
0
--
CD11c:CD18
--
e44
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m44
0
infinite
0
--
LPS:CD11c:CD18
--
e45
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m45
0
infinite
0
--
csml-variable:Double
m46
0
infinite
0
--
csml-variable:Double
m47
0
infinite
0
--
p73
--
e48
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m48
0
infinite
0
--
LPS:p73
--
e49
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m49
0
infinite
0
--
LPS
--
e5
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
LBP
--
e6
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
mAb3D7
--
e63
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m63
0
infinite
0
--
mAb5D3
--
e64
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m64
0
infinite
0
--
peptidoglycan:p73
--
e65
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m65
0
infinite
0
--
peptidoglycan
--
e66
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m66
0
infinite
0
--
unknown recptor
--
e67
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m67
0
infinite
0
--
LPS:Unknown receptor
--
e68
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m68
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m5*m6*0.1
nodelay
--
0
PMID: 7542643, 1698311 CD14 has been assigned a functional role, serving as a receptor for LPS in association with LBP in which heparinized human blood cultured for 16 h with LPS resulted in TNF-alpha production, whose synthesis and release could be nearly eliminated by pre-treatment with a CD14 blocking mAb
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c30 : 1
stoichiometry:c31 : 1
stoichiometry:c28 : 1
m21*m38*0.1
nodelay
--
0
PMID: 7542643, 7681082 A recent report described the importance of CD14 in LPS recognition by human monocytes and alveolar macrophages, leading to the synthesis and release of TNF-alpha, IL-6, and IL-8. The LPS-induced synthesis of these cytokines could be blocked with the anti-CD14 mAb MEM-18.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c33 : 1
stoichiometry:c34 : 1
m23*m24*0.1
nodelay
--
0
PMID: 7542643, 1708813 TNF-alpha, GM-CSF, G-CSF, and formyl peptide have been shown to induce a twofold increase in CD14 expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c35 : 1
m25*0.1
nodelay
--
0
PMID: 7542643, 1708813 TNF-alpha, GM-CSF, G-CSF, and formyl peptide have been shown to induce a twofold increase in CD14 expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m27*m28*0.1
nodelay
--
0
PMID: 7542643, 1708813 TNF-alpha, GM-CSF, G-CSF, and formyl peptide have been shown to induce a twofold increase in CD14 expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c40 : 1
m29*0.1
nodelay
--
0
PMID: 7542643, 1708813 TNF-alpha, GM-CSF, G-CSF, and formyl peptide have been shown to induce a twofold increase in CD14 expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m30*m31*0.1
nodelay
--
0
PMID: 7542643, 1708813 TNF-alpha, GM-CSF, G-CSF, and formyl peptide have been shown to induce a twofold increase in CD14 expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c45 : 1
m32*0.1
nodelay
--
0
PMID: 7542643, 1708813 TNF-alpha, GM-CSF, G-CSF, and formyl peptide have been shown to induce a twofold increase in CD14 expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c47 : 1
m38*0.1
nodelay
--
0
PMID: 7542643 LPS appears to upregulate CD 14 transcripts, followed by increased expression of CDI4 protein on the cell surface.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c49 : 1
m26*m38*0.1
nodelay
--
0
PMID: 7542643 LPS appears to upregulate CD 14 transcripts, followed by increased expression of CDI4 protein on the cell surface.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m5*m34*0.1
nodelay
--
0
PMID: 7542643 recombinant sCD14 produced using a baculovirus expression system was shown to specifically bind LPS
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c12 : 1
stoichiometry:c61 : 1
stoichiometry:c62 : 1
m12*m11*0.1
nodelay
--
0
PMID: 7542643, 1698311 CD14 has been assigned a functional role, serving as a receptor for LPS in association with LBP in which heparinized human blood cultured for 16 h with LPS resulted in TNF-alpha production, whose synthesis and release could be nearly eliminated by pre-treatment with a CD14 blocking mAb. Binding of erythrocyte- LPS complexes to macrophages could be inhibited by preincubation of macrophages with anti-CD14 blocking mAb.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c92 : 1
stoichiometry:c55 : 1
m35*0.1
nodelay
--
0
PMID: 7542643 Inhibition of LPS induced IL-6 and E-selectin expression by anti-CD14 mAb was maximal at low concentrations of LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c11 : 1
stoichiometry:c58 : 1
m35*0.1
nodelay
--
0
PMID: 7542643 Inhibition of LPSinduced IL-6 and E-selectin expression by anti-CD14 mAb was maximal at low concentrations of LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c6 : 1
m11*0.1
nodelay
--
0
PMID: 7542643, 2402637 In rabbit peritoneal macrophages, addition of LBP enhanced TNF-alpha production when cells were stimulated with LPS. This increase in TNF-alpha protein was accompanied by a concomitant increase in the rate and synthesis of TNF-alpha mRNA as visualized on Northern blots.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c66 : 1
stoichiometry:c91 : 1
stoichiometry:c65 : 1
m14*m11*0.1
nodelay
--
0
PMID: 7542643, 2402637 In rabbit peritoneal macrophages, addition of LBP enhanced TNF-alpha production when cells were stimulated with LPS. This increase in TNF-alpha protein was accompanied by a concomitant increase in the rate and synthesis of TNF-alpha mRNA as visualized on Northern blots. PMID: 7542643, 1698311 CD14 has been assigned a functional role, serving as a receptor for LPS in association with LBP in which heparinized human blood cultured for 16 h with LPS resulted in TNF-alpha production, whose synthesis and release could be nearly eliminated by pre-treatment with a CD14 blocking mAb
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c67 : 1
m11*0.1
nodelay
--
0
PMID: 7542643, 1607653 when LBP was added during LPS stimulation, macrophages responded with a more rapid induction of TNF-alpha and IL-lbeta mRNA, higher steady state mRNA levels, and increased mRNA stability which was shown to correlate with increased TNF-alpha and IL-lbeta protein.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c71 : 1
stoichiometry:c70 : 1
m13*m11*0.1
nodelay
--
0
PMID: 7542643, 1607653 when LBP was added during LPS stimulation, macrophages responded with a more rapid induction of TNF-alpha and IL-lbeta mRNA, higher steady state mRNA levels, and increased mRNA stability which was shown to correlate with increased TNF-alpha and IL-lbeta protein.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
stoichiometry:c74 : 1
m40*m5*0.1
nodelay
--
0
PMID: 7542643 All three members of the CD18 family (CDlla/CD18, CDllb/CD18, and CD 1Ic/CD 18) are capable of binding LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m5*m42*0.1
nodelay
--
0
PMID: 7542643 All three members of the CD18 family (CDlla/CD18, CDllb/CD18, and CD 1Ic/CD 18) are capable of binding LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m5*m44*0.1
nodelay
--
0
PMID: 7542643 All three members of the CD18 family (CDlla/CD18, CDllb/CD18, and CD 1Ic/CD 18) are capable of binding LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c90 : 1
stoichiometry:c81 : 1
m38*0.1
nodelay
--
0
PMID: 7542643, 1717586 LPS treatment has been shown to induce a rapid upregulation of CDllb/ CD 18 expression on human neutrophils, believed to be mediated by CD14, since anti-CD14 mAb specifically inhibited LPS-induced CDllb/CD18 expression (Lynn et al., 1991).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c8 : 1
stoichiometry:c7 : 1
m38*0.1
nodelay
--
0
PMID: 7542643, 1698311 CD14 has been assigned a functional role, serving as a receptor for LPS in association with LBP in which heparinized human blood cultured for 16 h with LPS resulted in TNF-alpha production, whose synthesis and release could be nearly eliminated by pre-treatment with a CD14 blocking mAb
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c89 : 1
stoichiometry:c82 : 1
m38*0.1
nodelay
--
0
PMID: 7542643, 1717586 LPS treatment has been shown to induce a rapid upregulation of CDllb/ CD 18 expression on human neutrophils, believed to be mediated by CD14, since anti-CD14 mAb specifically inhibited LPS-induced CDllb/CD18 expression (Lynn et al., 1991).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
stoichiometry:c88 : 1
stoichiometry:c99 : 1
stoichiometry:c87 : 1
m5*m48*0.1
nodelay
--
0
PMID: 7542643, 2456339 one of the most well-characterized LPS receptors in addition to CD18 and CD14, is the 73 kDa (80 kDa) receptor. PMID: 7542643 Two mAb were obtained from a series of clones, designated mAb 3D7 and mAb 5D3 were able to inhibit the interaction of LPS with the 73 kDa LPS receptor in a dose-dependent manner, reflecting specificity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c95 : 1
stoichiometry:c94 : 1
m48*m66*0.1
nodelay
--
0
PMID: 7542643, 2002021 The p73 receptor has been demonstrated to bind soluble peptidoglycan on mouse B lymphocytes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c97 : 1
stoichiometry:c98 : 1
m5*m67*0.1
nodelay
--
0
PMID: 7542643, 7690343 A 38 kDa cell surface protein displaying affinity for LPS was identified on mouse lymphocytes, macrophages, splenocytes, J774.1 cells and 70Z/3 cells using 125I-ASD-LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c9 : 1
m33*0.1
nodelay
--
0
PMID: 7542643, 1708813 TNF-alpha, GM-CSF, G-CSF, and formyl peptide have been shown to induce a twofold increase in CD14 expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c14 : 1
m38*0.1
nodelay
--
0
PMID: 7542643, 1376258 CD14 plays an important role in macrophage production of IL-1 in response to LPS. The LPS-induced synthesis of these cytokines could be blocked with the anti-CD14 mAb MEM-18.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c18 : 1
stoichiometry:c19 : 1
stoichiometry:c17 : 1
m17*m38*0.1
nodelay
--
0
PMID: 7542643, 1376258 CD14 plays an important role in macrophage production of IL-1 in response to LPS. The LPS-induced synthesis of these cytokines could be blocked with the anti-CD14 mAb MEM-18.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c13 : 1
stoichiometry:c20 : 1
m38*0.1
nodelay
--
0
PMID: 7542643, 7681082 A recent report described the importance of CD14 in LPS recognition by human monocytes and alveolar macrophages, leading to the synthesis and release of TNF-alpha, IL-6, and IL-8. The LPS-induced synthesis of these cytokines could be blocked with the anti-CD14 mAb MEM-18. PMID: 7542643 Inhibition of LPS induced IL-6 and E-selectin expression by anti-CD14 mAb was maximal at low concentrations of LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c26 : 1
m38*0.1
nodelay
--
0
PMID: 7542643, 7681082 A recent report described the importance of CD14 in LPS recognition by human monocytes and alveolar macrophages, leading to the synthesis and release of TNF-alpha, IL-6, and IL-8. The LPS-induced synthesis of these cytokines could be blocked with the anti-CD14 mAb MEM-18.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c25 : 1
stoichiometry:c24 : 1
stoichiometry:c23 : 1
m19*m38*0.1
nodelay
--
0
PMID: 7542643, 7681082 A recent report described the importance of CD14 in LPS recognition by human monocytes and alveolar macrophages, leading to the synthesis and release of TNF-alpha, IL-6, and IL-8. The LPS-induced synthesis of these cytokines could be blocked with the anti-CD14 mAb MEM-18.
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--